Cargando…

Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2

Despite effective vaccination programs, waning immunity in the vaccinated populations and the emergence of variants of concern posed a risk of breakthrough infections. A booster dose was demonstrated to provide substantially increased protection against symptomatic disease and hospitalization. We ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaggaiahgari, Shashidhar, Munigela, Apoorva, Mitnala, Sasikala, Gujjarlapudi, Deepika, Simhadri, Venu, D, Nageshwar Reddy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781398/ https://www.ncbi.nlm.nih.gov/pubmed/36560556 http://dx.doi.org/10.3390/vaccines10122146

Ejemplares similares

Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals
por: Sasikala, Mitnala, et al.
Publicado: (2021)

Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Patients with decompensated cirrhosis and liver transplant recipients demonstrate poor humoral and cellular immune response against COVID-19 vaccine
por: Kulkarni, Anand, et al.
Publicado: (2022)

Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152)
por: Munigela, Apoorva, et al.
Publicado: (2022)

Association of Lower Antispike Antibody Levels with Mortality in ICU Patients with COVID-19 Disease
por: Yelle, Sangeeta, et al.
Publicado: (2023)

High‐resolution HLA genotyping identifies alleles associated with severe COVID‐19: A preliminary study from India
por: Vishnubhotla, Ravikanth, et al.
Publicado: (2021)

Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial
por: Thuluva, Subhash, et al.
Publicado: (2023)

Effect of COVID-19 Vaccination on the Levels of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Naive, Hybrid, and Breakthrough SARS-CoV-2 Recovered Indian Individuals
por: Deepika, Gujjarlapudi, et al.
Publicado: (2023)

Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities
por: Jandhyala, Sai Manasa, et al.
Publicado: (2017)

Retinal venous occlusion in a child following Corbevax COVID-19 vaccination
por: Nangia, Purna, et al.
Publicado: (2022)

Immunogenicity of ChAdOx1 (Covishield) Booster Dose in Healthcare Providers: A Pre-Post Study
por: Meher, Trupti, et al.
Publicado: (2023)

Comment on: Retinal venous occlusion in a child following Corbevax COVID-19 vaccination
por: Panigrahi, Pradeep Kumar, et al.
Publicado: (2023)

Hairdye-Induced Hepatitis: An Unusal Cause of Acute Hepatitis
por: Gokak, Varadaraj P., et al.
Publicado: (2009)

Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time
por: Sharma, Mithun, et al.
Publicado: (2020)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Acinar injury and early cytokine response in human acute biliary pancreatitis
por: Jakkampudi, Aparna, et al.
Publicado: (2017)

Comparison of saliva with healthcare workers- and patient-collected swabs in the diagnosis of COVID-19 in a large cohort
por: Sasikala, Mitnala, et al.
Publicado: (2021)

Alterations in the pH of pancreatic juice are associated with chymotrypsin C inactivation and lithostathine precipitation in chronic pancreatitis patients: a proteomic approach
por: Goudshelwar, Renuka, et al.
Publicado: (2022)

Waning of Antibody Response Among Vaccinees who Received Two Doses of Covishield Vaccine
por: Haritay, Shivani, et al.
Publicado: (2023)

Pancreatic stellate cell: Pandora's box for pancreatic disease biology
por: Bynigeri, Ratnakar R, et al.
Publicado: (2017)

Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities
por: Bale, Govardhan, et al.
Publicado: (2017)

Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses
por: Eyer-Silva, Walter de Araujo, et al.
Publicado: (2022)

Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
por: Deng, Jie, et al.
Publicado: (2022)

Falsified COVISHIELD products in India and Uganda
Publicado: (2021)

Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults
por: Rakshit, Srabanti, et al.
Publicado: (2022)

Adverse effects after first and second dose of covishield and covaxin: A longitudinal study
por: Mittal, Amit, et al.
Publicado: (2022)

Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study
por: Rose, Winsley, et al.
Publicado: (2023)

Homologous and Heterologous Covid-19 Booster Vaccinations
por: Atmar, Robert L., et al.
Publicado: (2022)

Harada-like syndrome post-Covishield vaccination: A rare adverse effect
por: Reddy, Yogya, et al.
Publicado: (2022)

Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
por: Atmar, Robert L., et al.
Publicado: (2021)

Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans
por: Mayr, Florian B., et al.
Publicado: (2022)

Covid-19 vaccine (covishield) heralding Moyamoya angiopathy()()()
por: Das, Shambaditya, et al.
Publicado: (2022)

Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection
por: Mukherjee, RM, et al.
Publicado: (2010)

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron
por: Accorsi, Emma K., et al.
Publicado: (2022)

AEs after homologous versus heterologous COVID-19 booster
Publicado: (2022)

IgA antibody dynamics in healthcare workers after CoronaVac® vaccination and heterologous Comirnaty® booster dose
por: Bochnia-Bueno, Lucas, et al.
Publicado: (2023)

“Covishield and Covaxin” – India's contribution to global COVID-19 pandemic
por: Raina, Sunil Kumar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6t18k4uiqu6mjhlh9sdai1023o